Haidong Dong (H Dong)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Venues

bioRxiv : the preprint server for biology

Nature communications

ImmunoHorizons

Clinical cancer research : an official journal of the American Association for Cancer Research

Mayo Clinic Rochester

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Rochester

United States

Professor/Consultant :: Urology and Immunology

Publications

Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Nicholas D Sun, Allison R Carr, Erica N Krogman, Yogesh Chawla, Jun Zhong, Matthew C Guttormson, Mark Chan, Michelle A Hsu, Haidong Dong, Dusan Bogunovic, Akhilesh Pandey, Laura M Rogers, Adrian T Ting
TBK1 and IKKε protect target cells from IFNγ-mediated T cell killing via an inflammatory apoptotic mechanism. bioRxiv : the preprint server for biology (2024)
Nicholas D Sun, Allison R Carr, Erica N Krogman, Yogesh Chawla, Jun Zhong, Matthew C Guttormson, Mark Chan, Michelle A Hsu, Haidong Dong, Dusan Bogunovic, Akhilesh Pandey, Laura M Rogers, Adrian T Ting
TBK1 and IKKε protect target cells from IFNγ-mediated T cell killing via an inflammatory apoptotic mechanism. bioRxiv : the preprint server for biology (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Nicholas D Sun, Allison R Carr, Erica N Krogman, Yogesh Chawla, Jun Zhong, Matthew C Guttormson, Mark Chan, Michelle A Hsu, Haidong Dong, Dusan Bogunovic, Akhilesh Pandey, Laura M Rogers, Adrian T Ting
TBK1 and IKKε protect target cells from IFNγ-mediated T cell killing via an inflammatory apoptotic mechanism. bioRxiv : the preprint server for biology (2024)
Emilien Loeuillard, Binbin Li, Hannah E Stumpf, Jingchun Yang, Jennifer L Tomlinson, Rondell P Graham, Rory L Smoot, Haidong Dong, Sumera Irie Ilyas
Noncanonical TRAIL Signaling Facilitates Tumor Immunosuppression and Cholangiocarcinoma Growth via Myeloid-Derived Suppressor Cells. bioRxiv : the preprint server for biology (2023)
Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haidong Dong
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons 7 (1) (2023)
Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P Petrylak, William Kevin Kelly, E Premkumar Reddy, Liguo Wang, Matthew J Schiewer, Amaia Lujambio, Robert Jeffrey Karnes, Beatrice Knudsen, Carlos Cordon-Cardo, Haidong Dong, Zhenlin Huang, Arkaitz Carracedo, Yujin Hoshida, Veronica Rodriguez-Bravo, Josep Domingo-Domenech
Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. Cancer discovery (2023)
Joanina K Gicobi, Zhiming Mao, Grace DeFranco, Jacob B Hirdler, Ying Li, Vianca V Vianzon, Emilia R Dellacecca, Michelle A Hsu, Whitney Barham, Yiyi Yan, Aaron S Mansfield, Yi Lin, Xiaosheng Wu, Taro Hitosugi, Dawn Owen, Michael P Grams, Jacob J Orme, Fabrice Lucien, Hu Zeng, Sean S Park, Haidong Dong
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8 + T cells via ME1 up-regulation. Science advances 9 (46) (2023)
Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haidong Dong
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons 7 (1) (2023)
Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haidong Dong
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons 7 (1) (2023)
Zesheng An, Michelle A Hsu, Joanina K Gicobi, Tianxiao Xu, Susan M Harrington, Henan Zhang, Kevin D Pavelko, Jacob B Hirdler, Christine M Lohse, Reza Nabavizadeh, Rodrigo R Pessoa, Vidit Sharma, R Houston Thompson, Bradley C Leibovich, Haidong Dong, Fabrice Lucien
A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma. Journal of immunology (Baltimore, Md. : 1950) (2023)
Mojun Zhu, Henan Zhang, Katrina S Pedersen, Nathan R Foster, Brandy L Jaszewski, Xin Liu, Jacob B Hirdler, Zesheng An, Tanios S Bekaii-Saab, Thorvardur R Halfdanarson, Patrick M Boland, Yiyi Yan, Joleen H Hubbard, Wen Wee Ma, Harry H Yoon, Alexander Revzin, Martin E Fernandez-Zapico, Michael J Overman, Robert R McWilliams, Haidong Dong
Understanding Suboptimal Response to Immune Checkpoint Inhibitors. Advanced biology (2022)
Mojun Zhu, Chunhua Chen, Nathan R Foster, Christopher Hartley, Taofic Mounajjed, Marcela A Salomao, Briant F Fruth, Staci E Beamer, Yohan Kim, Susan M Harrington, Henry C Pitot, Cristobal T Sanhueza, Yening Feng, Joerg Herrmann, Robert R McWilliams, Fabrice Lucien, Bing Q Huang, Wen Wee Ma, Tanios S Bekaii-Saab, Haidong Dong, Dennis Wigle, Daniel H Ahn, Chris L Hallemeier, Shanda H Blackmon, Harry H Yoon
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (14) (2022)
David J Friedman, Monika Kizerwetter, Paul J Belmonte, Matthew Rajcula, Keith Theodore, Hyun Se Kim Lee, Michael Jeremy Shapiro, Haidong Dong, Virginia Smith Shapiro
Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice. Journal of immunology (Baltimore, Md. : 1950) 208 (8) (2022)
Joanina K Gicobi, Emilia R Dellacecca, Haidong Dong
Resilient T-cell responses in patients with advanced cancers. International journal of hematology (2022)
Harry H Yoon, Haidong Dong, Qian Shi
Impact of PD-1 Blockade in Nonresponders: Pitfalls and Promise. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Ti Wen, Whitney Barham, Ying Li, Henan Zhang, Joanina K Gicobi, Jacob B Hirdler, Xin Liu, Hyoungjun Ham, Kodi E Peterson Martinez, Fabrice Lucien, Roxane R Lavoie, Hu Li, Cristina Correia, Dileep D Monie, Zesheng An, Susan M Harrington, Xiaosheng Wu, Ruifeng Guo, Roxana S Dronca, Aaron S Mansfield, Yiyi Yan, Svetomir N Markovic, Sean S Park, Jie Sun, Hong Qin, Minetta C Liu, George Vasmatzis, Daniel D Billadeau, Haidong Dong
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy. Cancer immunology research 10 (2) (2021)
Yan W Asmann, Kaushal Parikh, Peter Leif Bergsagel, Haidong Dong, Alex A Adjei, Mitesh J Borad, Aaron S Mansfield
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups. NPJ precision oncology 5 (1) (2021)
David J Friedman, Sydney B Crotts, Michael Jeremy Shapiro, Matthew Rajcula, Shaylene McCue, Xin Liu, Khashayarsha Khazaie, Haidong Dong, Virginia Smith Shapiro
ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses. Cancer immunology research 9 (8) (2021)
Henan Zhang, Jacob J Orme, Feven Abraha, B J Stish, Val J Lowe, Fabrice Lucien, Erik J Tryggestad, Michael S Bold, Lance C Pagliaro, C Richard Choo, Debra H Brinkmann, Matthew J Iott, Brian J Davis, J Fernando Quevedo, William S Harmsen, Brian A Costello, Geoffrey B Johnson, Mark A Nathan, Kenneth R Olivier, Thomas M Pisansky, Eugene D Kwon, Haidong Dong, Sean S Park
Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
In Su Cheon, C Li, Young Min Son, Nicholas P Goplen, Yue Wu, T Cassmann, Zheng Wang, Xiaoqin Wei, Jin-Yi Tang, Y Li, H Marlow, S Hughes, L Hammel, T M Cox, E Goddery, K Ayasoufi, Daniela Weiskopf, Jim Boonyaratanakornkit, Haidong Dong, Hu Li, Rana Chakaraborty, Aaron J Johnson, E Edell, Justin James Taylor, Mark H Kaplan, Alessandro Sette, Brian J Bartholmai, Ryan Kern, Robert A Vassallo, Jie Sun
Immune signatures underlying post-acute COVID-19 lung sequelae. Science immunology 6 (65) (2021)
Rachel M Gibbons Johnson, Ti Wen, Haidong Dong
Bidirectional signals of PD-L1 in T cells that fraternize with cancer cells. Nature immunology 21 (4) (2020)
Kostandinos Sideras, Robert A de Man, Susan M Harrington, Wojciech G Polak, Guoying Zhou, Hannah M Schutz, Alexander Pedroza-González, Katharina Biermann, Shanta Mancham, Bettina E Hansen, R Bart Takkenberg, Anneke J van Vuuren, Maikel P Peppelenbosch, Jan N M Ijzermans, Stefan Sleijfer, Dave Sprengers, Haidong Dong, Jaap Kwekkeboom, Marco J Bruno
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels. Scientific reports 9 (1) (2019)
Aaron S Mansfield, Hongzheng Ren, Shari Sutor, Vivekananda Sarangi, Asha Nair, Jaime I Davila, Laura R Elsbernd, Julia B Udell, Roxana S Dronca, Sean S Park, Svetomir N Markovic, Zhifu Sun, Kevin C Halling, Wendy K Nevala, Marie Christine Aubry, Haidong Dong, Jin Jen
Contraction of T cell richness in lung cancer brain metastases. Scientific reports 8 (1) (2018)
Yong Liang, Haidong Tang, Jingya Guo, Xiangyan Qiu, Zecheng Yang, Zhenhua Ren, Zhichen Sun, Yingjie Bian, Lily Xu, Hairong Xu, Jiao Shen, Yanfei Han, Haidong Dong, Hua Peng, Yang-Xin Fu
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance. Nature communications 9 (1) (2018)

Haidong Dong.css-eqlu8i{font-size:small;padding-left:4px;} (H Dong)

Publication Activity (10 Years)

Top Topics

Top Venues

Haidong Dong (H Dong)